ALTAVOL
Live / Registered — Registered (as of 29 Jul 2025)
What this means for you
Registered since 29 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79395459
- Registration number
- 7873757
- Mark type
- Stylized text
- Filed
- 15 Jan 2024
- Published for opposition
- 29 Apr 2025
- Registered
- 29 Jul 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in the treatment of hematology diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in the treatment of ophthalmology diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
- Class 010 — Medical apparatus: [ Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; ] Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention, and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention, and treatment of hematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention, and treatment of eye diseases and eye conditions; [ medical apparatus and instruments for the diagnosis, prevention, and treatment of heart rhythm disorders; ] medical apparatus and instruments for the diagnosis, prevention, and treatment of immune system diseases and disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of kidney diseases; [ medical apparatus and instruments for the diagnosis, prevention, and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention, and treatment of hypertension; ] medical apparatus and instruments for the diagnosis, prevention, and treatment of skin disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of urinary diseases and disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of ophthalmological diseases and disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention, and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention, and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention, and treatment of respiratory diseases and asthma; radiological apparatus for medical purposes and instruments being radiological apparatus for medical purposes; genetic testing apparatus for medical purposes and instruments being genetic testing apparatus for medical purposes; electromagnetic drug delivery apparatus for medical use and instruments being electromagnetic drug delivery apparatus for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments being medical diagnostic apparatus for testing DNA and RNA samples for medical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments being medical apparatus for introducing pharmaceutical preparations into the human body
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 12 Mar 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Feb 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Feb 2026 — FINAL DISPOSITION PROCESSED
- 19 Feb 2026 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 02 Dec 2025 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 10 Nov 2025 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 03 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Oct 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 24 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 08 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 20 Aug 2025 — TEAS SECTION 7 REQUEST RECEIVED
- 29 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 09 Jul 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED